EFFICACY AND SAFETY OF PIDOTIMOD IN THE TREATMENT OF RECURRENT RESPIRATORY INFECTIONS IN CHILDREN
<em>The immunomodulating activity of pidotimod (imunorix) was evaluated in a doublebblind, placebobcontrolled, randomized, multicentre trial, on 120 pediatric patients affected by recurrent respiratory infections. Antibiotic therapy and time of hospitalization were shorter in the patients taki...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
"Paediatrician" Publishers LLC
2008-01-01
|
Series: | Вопросы современной педиатрии |
Subjects: | |
Online Access: | http://vsp.spr-journal.ru:80/jour/article/view/1371 |